2006
DOI: 10.1177/108155890605401s116
|View full text |Cite
|
Sign up to set email alerts
|

Hemodynamic Compromise Rejection Predicts Future Cardiac Allograft Vasculopathy and Nonfatal Major Adverse Cardiac Events

Abstract: enzyme was measured in a lactonase assay using 5-HETE lactone as the substrate. The results showed no significant difference in lactonase activity between the wild-type and variant enzymes. Based on these preliminary studies, we conclude that PON2 lactonase activity may not be associated with the predicted epidemiological link between PON2 polymorphisms and cardiovascular disease.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles